Generous donations and the support of the NSW Government have allowed us to construct the Garvan-Weizmann Centre for Cellular Genomics, solidifying the partnership and building a remarkable interdisciplinary research centre. However, it is the research that will be produced through the Centre, and through the partnership, that will shape the future.
We seek philanthropic investment into the cutting-edge collaborative research projects that will be driven by the Centre’s technologies and expertise. These projects draw on deep research insights from both Institutes and make full use of the capabilities of the new technologies.
Before our partnership was formalised, there were already a number of research teams at the Garvan and Weizmann Institutes working together. Now, we are seeing how the Garvan-Weizmann partnership will strengthen and accelerate those collaborations.
The Garvan-Weizmann partnership has fostered bold and inventive projects that seek to understand key aspects of melanoma, breast cancer, the spread of cancers to bone, cancer immunotherapy, immunology and diabetes – and ultimately to affect outcomes for individuals with these diseases. I invite you to explore five of the inaugural research projects here.
Importantly, the Centre’s facilities will be available to researchers beyond those at Garvan and Weizmann, kick-starting an era of rapid advances in the cell-by-cell understanding of how our tissues function in health and disease.
If you can, please consider investing in the innovative research of the Garvan Institute of Medical Research and the Weizmann Institute of Science.
Mr Andrew Giles
Chief Executive Officer, Garvan Research Foundation
If you would like to discuss supporting the Garvan-Weizmann partnership, please call Andrew on +61 (0) 2 9295 8513 or email firstname.lastname@example.org